Cash from Operations (Annual) Chart

View Cash from Operations (Annual) for PTN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Operations (Annual) Chart
Start Trial

Historical Cash from Operations (Annual) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2025 -21.31M
June 30, 2024 -31.46M
June 30, 2023 -29.27M
June 30, 2022 -29.92M
June 30, 2021 -22.65M
June 30, 2020 41.33M
June 30, 2019 -21.78M
June 30, 2018 1.703M
June 30, 2017 12.88M
June 30, 2016 -47.36M
June 30, 2015 -13.36M
June 30, 2014 -12.21M
June 30, 2013 -13.65M
June 30, 2012 -15.49M
Date Value
June 30, 2011 -11.03M
June 30, 2010 -5.730M
June 30, 2009 -5.444M
June 30, 2008 -20.58M
June 30, 2007 -22.05M
June 30, 2006 -23.45M
June 30, 2005 -5.064M
June 30, 2004 -23.74M
June 30, 2003 -19.89M
June 30, 2002 -13.15M
June 30, 2001 -8.397M
June 30, 2000 -8.540M
June 30, 1999 -10.05M
June 30, 1998 -7.432M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (Annual) Range, Past 5 Years

View Cash from Operations (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (Annual) Benchmarks

View Cash from Operations (Annual) Benchmarks
Start Trial
Decoy Therapeutics, Inc. -4.827M
ACADIA Pharmaceuticals, Inc. 109.84M
Alnylam Pharmaceuticals, Inc. 524.08M
Anika Therapeutics, Inc. 11.19M
Savara, Inc. -101.04M